What is the price target for ABUS stock?
9 analysts have analysed ABUS and the average price target is 5.78 USD. This implies a price increase of 39.28% is expected in the next year compared to the current price of 4.15.
ARBUTUS BIOPHARMA CORP (ABUS) Forecast, Price Target & Analyst Ratings
NASDAQ:ABUS • CA03879J1003
Current stock price
4.15 USD
-0.15 (-3.49%)
At close:
4.1957 USD
+0.05 (+1.1%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ARBUTUS BIOPHARMA CORP (ABUS).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Apr 30, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.04
- Revenue Estimate
- 408K
Price Target Details & History
Consensus Price Target and Range
Mean target
$5.78
Upside
+ 39.28%
From current price of $4.15 to mean target of $5.78, Based on 9 analyst forecasts
Low
$5.05
Median
$5.10
High
$7.35
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
9 Wall Street analysts provided a forecast for the next 12 months for ABUS. The average price target is 5.78 USD. This implies a price increase of 39.28% is expected in the next year compared to the current price of 4.15.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
84.44%
ABUS was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about ABUS.
In the previous month the buy percentage consensus was at a similar level.
ABUS was analyzed by 9 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-11-14 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-08-11 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-03-28 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-01-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-20 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-11-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-06 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-09-05 | Jefferies | Maintains | Buy -> Buy |
| 2024-08-02 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-06-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-05 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-05-03 | Chardan Capital | Reiterate | Buy -> Buy |
| 2024-04-04 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-03-01 | Chardan Capital | Reiterate | Buy -> Buy |
| 2024-03-01 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-09-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-04 | Chardan Capital | Reiterate | Buy -> Buy |
| 2023-08-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-07-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-07-06 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2023-06-22 | Chardan Capital | Reiterate | Buy -> Buy |
| 2023-06-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-05 | HC Wainwright & Co. | Reiterate | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Apr 30, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.04
- Revenue Estimate
- 408K
- Revenue Q2Q
- -76.87%
- EPS Q2Q
- 68.62%
- Number of Analysts
- 3
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%
Next Earnings Summary
ABUS is expected to report earnings on 4/30/2026. The consensus EPS estimate for the next earnings is -0.04 USD and the consensus revenue estimate is 408.00K USD.
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.
Full Analyst Estimates 2026 - 2029
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 18.141M -53.51% | 6.171M -65.98% | 14.083M 128.21% | 1.02M -92.76% | 9.009M 783.24% | 57.051M 533.27% | 176.95M 210.16% | |
| EBITDA YoY % growth | -76.699M -19.79% | -71.219M 7.14% | -24.858M 65.10% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -78.103M -19.31% | -72.599M 7.05% | -25.221M 65.26% | -49.119M -94.75% | -17.585M 64.20% | -37.195M -111.52% | 68.191M 283.33% | |
| Operating Margin | -430.53% | -1,176.45% | -179.09% | -4,815.60% | -195.19% | -65.20% | 38.54% | |
| EPS YoY % growth | -0.44 6.57% | -0.37 15.91% | -0.18 51.35% | -0.16 9.33% | -0.05 68.75% | -0.14 -179.40% | 0.35 343.52% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.04 68.62% | -0.04 -508.00% | -0.04 -2.00% | -0.04 -104.00% |
| Revenue Q2Q % growth | 408K -76.87% | 204K -98.10% | 204K -61.44% | 102K -90.29% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -11.275M 15.39% | -11.903M -820.11% | -12.593M -47.10% | -13.349M -167.67% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
6.51%
EPS Next 5 Year
40.78%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
60.10%
Revenue Next 5 Year
88.88%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
ARBUTUS BIOPHARMA CORP / ABUS Forecast FAQ
What is the next earnings date for ABUS stock?
ARBUTUS BIOPHARMA CORP (ABUS) will report earnings on 2026-04-30.
What are the consensus estimates for ABUS stock next earnings?
The consensus EPS estimate for the next earnings of ARBUTUS BIOPHARMA CORP (ABUS) is -0.04 USD and the consensus revenue estimate is 408.00K USD.
How many analysts cover ARBUTUS BIOPHARMA CORP (ABUS) stock?
The number of analysts covering ARBUTUS BIOPHARMA CORP (ABUS) is 9.